Target Name: AAMP
NCBI ID: G14
Review Report on AAMP Target / Biomarker Content of Review Report on AAMP Target / Biomarker
AAMP
Other Name(s): Angio associated migratory cell protein, transcript variant 1 | AAMP_HUMAN | Angio-associated migratory cell protein | Angio-associated migratory cell protein (isoform 1) | OTTHUMP00000207409 | Angio associated migratory cell protein, transcript variant 2 | AAMP variant 1 | OTTHUMP00000207408 | Angio-associated migratory cell protein (isoform 2) | angio associated migratory cell protein | OTTHUMP00000207410 | AAMP variant 2

AAMP: A Potential Drug Target Or Biomarker

Angio associated migratory cell protein (AAMP), also known as transcript variant 1, is a protein that is expressed in the endothelial cells of the body. It plays a crucial role in the development and maintenance of blood vessels, including arteries, veins, and capillaries. AAMP is also involved in the regulation of blood pressure, and has been shown to have anti-inflammatory and pro-inflammatory effects.

AAMP has been identified as a potential drug target or biomarker due to its unique biology and the diseases it is associated with. One of the main reasons for its potential as a drug target is its involvement in the regulation of blood pressure. High blood pressure, also known as hypertension, is a leading risk factor for cardiovascular disease and is associated with a wide range of health problems, including heart attacks, strokes, and heart failure.

AAMP has been shown to have a positive effect on blood pressure by increasing the diameter of blood vessels, which can help to reduce the pressure on the blood vessels. In addition, AAMP has also been shown to decrease the activity of a protein called AQP2, which is involved in the regulation of blood pressure. This suggests that AAMP may be an effective way to lower blood pressure and reduce the risk of cardiovascular disease.

Another potential drug target for AAMP is its role in the regulation of inflammation. Chronic inflammation is associated with a wide range of diseases, including heart disease, cancer, and autoimmune disorders. AAMP has been shown to have a negative effect on inflammation by regulating the activity of immune cells and reducing the production of pro-inflammatory molecules. This suggests that AAMP may be an effective way to treat inflammatory diseases.

In addition to its potential as a drug target, AAMP is also a potential biomarker for a variety of diseases. The regulation of blood vessels is a critical function for many biological processes in the body, and changes in the regulation of blood vessels can be associated with a wide range of diseases, including heart disease, cancer, and neurological disorders.

AAMP may be an effective way to diagnose and monitor certain types of cancer, as it has been shown to be expressed in the blood vessels of cancer cells. This suggests that AAMP may be a useful biomarker for the detection and treatment of cancer. In addition, AAMP may also be an effective way to diagnose and monitor autoimmune disorders, as it has been shown to be involved in the regulation of immune cells.

Overall, AAMP is a protein that has a unique biology and is involved in the regulation of blood vessels. Its potential as a drug target or biomarker makes it an attractive target for research into the treatment of a wide range of diseases. Further studies are needed to fully understand the biology of AAMP and its potential as a drug or biomarker.

Protein Name: Angio Associated Migratory Cell Protein

Functions: Plays a role in angiogenesis and cell migration. In smooth muscle cell migration, may act through the RhoA pathway

The "AAMP Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about AAMP comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets

AANAT | AAR2 | AARD | AARS1 | AARS2 | AARSD1 | AASDH | AASDHPPT | AASS | AATBC | AATF | AATK | ABALON | ABAT | ABCA1 | ABCA10 | ABCA11P | ABCA12 | ABCA13 | ABCA17P | ABCA2 | ABCA3 | ABCA4 | ABCA5 | ABCA6 | ABCA7 | ABCA8 | ABCA9 | ABCB1 | ABCB10 | ABCB11 | ABCB4 | ABCB5 | ABCB6 | ABCB7 | ABCB8 | ABCB9 | ABCC1 | ABCC10 | ABCC11 | ABCC12 | ABCC13 | ABCC2 | ABCC3 | ABCC4 | ABCC5 | ABCC6 | ABCC6P1 | ABCC6P2 | ABCC8 | ABCC9 | ABCD1 | ABCD2 | ABCD3 | ABCD4 | ABCE1 | ABCF1 | ABCF1-DT | ABCF2 | ABCF3 | ABCG1 | ABCG2 | ABCG4 | ABCG5 | ABCG8 | ABHD1 | ABHD10 | ABHD11 | ABHD11-AS1 | ABHD12 | ABHD12B | ABHD13 | ABHD14A | ABHD14B | ABHD15 | ABHD16A | ABHD16B | ABHD17A | ABHD17AP1 | ABHD17AP4 | ABHD17AP5 | ABHD17AP6 | ABHD17B | ABHD17C | ABHD18 | ABHD2 | ABHD3 | ABHD4 | ABHD5 | ABHD6 | ABHD8 | ABI1 | ABI2 | ABI3 | ABI3BP | ABITRAM | ABL1 | ABL2 | ABLIM1 | ABLIM2